Hepatocellular Carcinoma (hcc) - Pharma

Relevant Publications

Improving hepatocellular carcinoma surveillance in the United Kingdom: challenges and solutions.

Issue Release: 2024

ONC206 targeting ClpP induces mitochondrial dysfunction and protective autophagy in hepatocellular carcinoma cells.

Issue Release: 2024

LTR Retrotransposon-Derived LncRNA LINC01446 Promotes Hepatocellular Carcinoma Progression and Angiogenesis by Regulating the SRPK2/SRSF1/VEGF Axis.

Issue Release: 2024

Comparison of Clinical Manifestations and Related Factors of Hepatocellular Carcinoma with Chronic Hepatitis B.

Issue Release: 2024

The significance of lipid metabolism reprogramming of tumor-associated macrophages in hepatocellular carcinoma.

Issue Release: 2024

Functional hydrogels for hepatocellular carcinoma: therapy, imaging, and in vitro model.

Issue Release: 2024

Ramucirumab for advanced hepatocellular carcinoma in the current real world: a Japanese single-arm study post-REACH-2 (The R-evolution study).

Issue Release: 2024

Multi-omics analysis reveals mechanism of Schisandra chinensis lignans and acteoside on EMT in hepatoma cells via ERK1/2 pathway.

Issue Release: 2024

CD151-enriched migrasomes mediate hepatocellular carcinoma invasion by conditioning cancer cells and promoting angiogenesis.

Issue Release: 2024

Radiomics model based on contrast-enhanced computed tomography imaging for early recurrence monitoring after radical resection of AFP-negative hepatocellular carcinoma.

Issue Release: 2024

The role and mechanism of SUMO modification in liver disease.

Issue Release: 2024

Characterizations of multi-kingdom gut microbiota in immune checkpoint inhibitor-treated hepatocellular carcinoma.

Issue Release: 2024

Immunotherapy for hepatocellular carcinoma: the next evolution in expanding access to liver transplantation.

Issue Release: 2024

Review of current and new drugs for the treatment of metabolic-associated fatty liver disease.

Issue Release: 2024

SNX16 is required for hepatocellular carcinoma survival via modulating the EGFR-AKT signaling pathway.

Issue Release: 2024

Influence of Phase Change Droplet Activation and Microbubble Cavitation on the Microenvironment of Hepatocellular Carcinoma.

Issue Release: 2024

An herbal formula Shenlian decoction upregulates M1/M2 macrophage proportion in hepatocellular carcinoma by suppressing complement cascade.

Issue Release: 2024

Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040.

Issue Release: 2024

Diet, lifestyle factors, comorbidities, and hepatocellular carcinoma risk in a middle eastern country: a case-control study.

Issue Release: 2024

Hedgehog signaling mastery: R51211\'s promise in augmenting the therapeutic efficacy of sorafenib.

Issue Release: 2024

How Does Cellular Stress Impact Drug Development?

How are ADEs Detected and Reported?

What is Medication Management?

What is Cellular Stress?

How Can Pharma Companies Improve Patient Education?

What are the Key Challenges?

How Do Pharmacists Contribute to Patient Care?

What Types of Medications are Used?

What are Collaborative Care Models?

Why is Transitional Care Important in Pharma?

Partnered Content Networks

Relevant Topics